Nishanth Belugali Nataraj (Yosef Yarden, Nishanth B Nataraj)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Nature communications

Proceedings of the National Academy of Sciences of the United States of America

Science signaling

Biochemical Society transactions

This page only lists publications with an associated author ORCID identifier.

Publications

Yael Aylon, Noa Furth, Giuseppe Mallel, Gilgi Friedlander, Nishanth Belugali Nataraj, Meng Dong, Ori Hassin, Rawan Zoabi, Benjamin Cohen, Vanessa Drendel, Tomer Meir Salame, Saptaparna Mukherjee, Nofar Harpaz, Randy Johnson, Walter E Aulitzky, Yosef Yarden, Efrat Shema, Moshe Oren
Author Correction: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis. Nature communications 14 (1) (2023)
Yael Aylon, Noa Furth, Giuseppe Mallel, Gilgi Friedlander, Nishanth Belugali Nataraj, Meng Dong, Ori Hassin, Rawan Zoabi, Benjamin Cohen, Vanessa Drendel, Tomer Meir Salame, Saptaparna Mukherjee, Nofar Harpaz, Randy Johnson, Walter E Aulitzky, Yosef Yarden, Efrat Shema, Moshe Oren
Author Correction: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis. Nature communications 14 (1) (2023)
Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster, Moshit Lindzen, Saptaparna Mukherjee, Rainer Will, Soma Ghosh, Arturo Simoni-Nieves, Aakanksha Verma, Rishita Chatterjee, Simone Borgoni, Welles Robinson, Sanju Sinha, Alexander Brandis, D Lucas Kerr, Wei Wu, Arunachalam Sekar, Suvendu Giri, Youngmin Chung, Diana Drago-Garcia, Brian P Danysh, Mattia Lauriola, Michelangelo Fiorentino, Andrea Ardizzoni, Moshe Oren, Collin M Blakely, Jideofor Ezike, Stefan Wiemann, Laxmi Parida, Trever G Bivona, Rami I Aqeilan, Joan S Brugge, Aviv Regev, Gad A Getz, Eytan Ruppin, Yosef Yarden
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer. Cancer discovery 12 (11) (2022)
Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, Yael Aylon, Rona Yaeger, Giulia Fontemaggi, Saptaparna Mukherjee, Martino Maddalena, Adi Avioz, Ortal Iancu, Giuseppe Mallel, Anat Gershoni, Inna Grosheva, Ester Feldmesser, Shifra Ben-Dor, Ofra Golani, Ayal Hendel, Giovanni Blandino, David P Kelsen, Yosef Yarden, Moshe Oren
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients. Nature communications 13 (1) (2022)
Saptaparna Mukherjee, Martino Maddalena, YiQing Lü, Sebastien Martinez, Nishanth Belugali Nataraj, Ashish Noronha, Sansrity Sinha, Katie Teng, Victoria Cohen-Kaplan, Tamar Ziv, Sharathchandra Arandkar, Ori Hassin, Rishita Chatterjee, Anna-Chiara Pirona, Michal Shreberk-Shaked, Anat Gershoni, Yael Aylon, Zvulun Elazar, Yosef Yarden, Daniel Schramek, Moshe Oren
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins. Proceedings of the National Academy of Sciences of the United States of America 119 (17) (2022)
Nishanth Belugali Nataraj, Ilaria Marrocco, Nishanth Belugali Nataraj
Roles for growth factors and mutations in metastatic dissemination. Biochemical Society transactions 49 (3) (2022)
Yael Aylon, Noa Furth, Giuseppe Mallel, Gilgi Friedlander, Nishanth Belugali Nataraj, Meng Dong, Ori Hassin, Rawan Zoabi, Benjamin Cohen, Vanessa Drendel, Tomer Meir Salame, Saptaparna Mukherjee, Nofar Harpaz, Randy Johnson, Walter E Aulitzky, Yosef Yarden, Efrat Shema, Moshe Oren
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis. Nature communications 13 (1) (2022)
Anjana Shenoy, Nishanth Belugali Nataraj, Gili Perry, Fabricio Loayza Puch, Remco Nagel, Irina Marin, Nora Balint, Noa Bossel, Anya Pavlovsky, Iris Barshack, Bella Kaufman, Reuven Agami, Yosef Yarden, Maya Dadiani, Tamar Geiger
Proteomic patterns associated with response to breast cancer neoadjuvant treatment. Molecular systems biology 16 (9) (2021)
Ilaria Marrocco, Donatella Romaniello, Itay Vaknin, Diana Drago-Garcia, Roni Oren, Mary Luz Uribe, Nishanth Belugali Nataraj, Soma Ghosh, Raya Eilam, Tomer-Meir Salame, Moshit Lindzen, Yosef Yarden
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models. EMBO molecular medicine 13 (4) (2021)
Yuya Haga, Ilaria Marrocco, Ashish Noronha, Mary Luz Uribe, Nishanth Belugali Nataraj, Arunachalam Sekar, Diana Drago-Garcia, Simone Borgoni, Moshit Lindzen, Suvendu Giri, Stefan Wiemann, Yasuo Tsutsumi, Yosef Yarden
Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors. Cancer research 81 (14) (2021)
Martino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, Ori Hassin, Saptaparna Mukherjee, Sharathchandra Arandkar, Ron Rotkopf, Abby Kapsack, Giuseppina Lambiase, Bianca Pellegrino, Eyal Ben-Isaac, Ofra Golani, Yoseph Addadi, Emma Hajaj, Raya Eilam, Ravid Straussman, Yosef Yarden, Michal Lotem, Moshe Oren
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment. Proceedings of the National Academy of Sciences of the United States of America 118 (23) (2021)
Mary Luz Uribe, Maik Dahlhoff, Rajbir Nath Batra, Nishanth Belugali Nataraj, Yuya Haga, Diana Drago-Garcia, Ilaria Marrocco, Arunachalam Sekar, Soma Ghosh, Itay Vaknin, Sacha Lebon, Lior Kramarski, Yasuo Tsutsumi, Inpyo Choi, Oscar M Rueda, Carlos Caldas, Yosef Yarden
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis. Science signaling 14 (688) (2021)